BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT
BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT
批准号:
2332982
负责人:
John J Laterra
金额:
$20.62万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-02-01 至 1998-01-31
中文摘要
在美国,原发性脑肿瘤每年导致超过12,000人死亡。
只有国家。 现有的治疗方法大多无效。 船只─
靶向疗法具有显著的治疗潜力,
血管生成是实体瘤生长所必需的。 另外,血-
脑屏障功能障碍是脑血管病患者发病的主要原因。
脑瘤 由于血管周围神经胶质细胞与
在正常脑和神经胶质瘤内的微血管,我们已经在体内开发了
和体外方法来确定这些细胞
影响内皮细胞行为。 我们已经确定血管周围
纤溶酶原激活调节神经胶质瘤血管生成和生长,和
神经胶质瘤动物的存活率。 本申请的目的
是为了确定神经胶质瘤细胞改变CNS微血管的机制,
增长和差异化,并制定战略,
通过靶向纤溶酶原激活途径来提高患者存活率。
将在体外和体内实验大鼠和人类胶质瘤模型,
用于确定神经胶质瘤细胞影响血管生成的机制
和内皮分化。 在目标#1中,我们将确定如何
星形胶质细胞和胶质瘤细胞改变内皮细胞周围纤溶酶原激活
和微血管形态发生。 纤溶酶原激活剂(PA)和PA
抑制剂将被定量并定位在内皮细胞、神经胶质瘤和
混合胶质瘤内皮培养物。 纯化成分的效果
P6通道将被确定。 研究结果将揭示机制
PA通过其调节胶质瘤诱导的微血管形成。 目标#2
我们将确定其他胶质瘤细胞产物在血管生成过程中的作用,
体外细胞相互作用。 免疫细胞学和生物化学方法
将用于确定细胞粘附和去粘附的功能
分子、胶原蛋白、胶原酶和蛋白聚糖
胶质瘤-内皮细胞相互作用。 在目标#3中,我们将使用
免疫组织化学和生物化学技术,以确定是否特异性
PA、PAI、粘附分子和细胞外基质调节
正常脑和脑肿瘤中的微血管生长和分化
in vivo. 在目标#4中,我们将使用全身和间质药物递送
优化颅内胶质瘤治疗反应的策略
纤溶酶原激活抑制剂,并确定反应是否
由于对肿瘤微血管生长和内皮屏障的影响
表情 我们的发现将确定神经胶质瘤细胞
诱导病理性微血管反应并测试新血管靶向
治疗原发性脑肿瘤的方法。
英文摘要
Primary brain tumors cause over 12,000 deaths each year in the United
States alone. Existing therapies are largely ineffective. Vessel-
targeted therapies have substantial therapeutic potential since
angiogenesis is required for solid tumor growth. In addition, blood-
brain barrier dysfunction is a major cause of morbidity in patients with
brain tumors. Because of the relationship between perivascular glia and
microvessels within normal brain and gliomas, we have developed in vivo
and in vitro methodologies to determine mechanisms by which these cells
influence endothelial behavior. We have established that perivascular
plasminogen activation regulates glioma angiogenesis and growth, and
survival of glioma-bearing animals. The objectives of this application
are to determine mechanisms by which glioma cells alter CNS microvessel
growth and differentiation and to develop strategies for improving
patient survival by targeting the plasminogen activation pathway.
In vitro and in vivo experimental rat and human glioma models will be
used to determine mechanisms by which glioma cells influence angiogenesis
and endothelial differentiation. In aim #1 we will determine how
astrocytes and glioma cells alter periendothelial plasminogen activation
and microvessel morphogenesis. Plasminogen activators (PA) and PA
inhibitors will be quantitated and localized in endothelial, glioma, and
mixed glioma endothelial cultures. The effects of purified components
of the P6 pathway will be determined. Findings will reveal mechanisms
by which PAs regulate glioma-induced microvessel formation. In aim #2
we will establish roles of other glioma cell products during angiogenic
cell interactions in vitro. Immunocytological and biochemical methods
will be used to determine the functions of cell adhesion and de-adhesion
molecules, collagen, collagenases, and proteoglycans during angiogenic
glioma-endothelial interactions. In aim #3 we will use
immunohistochemical and biochemical techniques to determine if specific
PAs, PAIs, adhesion molecules, and extracellular matrix regulate
microvessel growth and differentiation in normal brain and brain tumors
in vivo. In aim #4 we will use systemic and interstitial drug delivery
strategies to optimize the therapeutic response of intracranial gliomas
to plasminogen activation inhibitors and to determine if responses are
due to effects on tumor microvessel growth and endothelial barrier
expression. Our findings will identify mechanisms by which glioma cells
induce pathological microvessel responses and test novel vessel-targeted
approaches to treating primary brain tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tet2 regulation and function in glioma cell phenotype reprogramming
-
批准号:10630929
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2019
-
负责人:John J Laterra
-
依托单位:
Tet2 regulation and function in glioma cell phenotype reprogramming
-
批准号:9817100
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2019
-
负责人:John J Laterra
-
依托单位:
Tet2 regulation and function in glioma cell phenotype reprogramming
-
批准号:10417120
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2019
-
负责人:John J Laterra
-
依托单位:
Tet2 regulation and function in glioma cell phenotype reprogramming
-
批准号:10171628
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2019
-
负责人:John J Laterra
-
依托单位:
Tet2 regulation and function in glioma cell phenotype reprogramming
-
批准号:9983217
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2019
-
负责人:John J Laterra
-
依托单位:
Chromatin Modifications in GBM-Propagating Cells
-
批准号:9886285
-
项目类别:
-
资助金额:$47.08万
-
财政年份:2017
-
负责人:John J Laterra
-
依托单位:
Chromatin Modifications in GBM-Propagating Cells
-
批准号:10115136
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2017
-
负责人:John J Laterra
-
依托单位:
Chromatin Modifications in GBM-Propagating Cells
-
批准号:9245073
-
项目类别:
-
资助金额:$41.81万
-
财政年份:2017
-
负责人:John J Laterra
-
依托单位:
Brain Cancer Stem Cell Reprogramming by c-Met
-
批准号:8464289
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2012
-
负责人:John J Laterra
-
依托单位:
Brain Cancer Stem Cell Reprogramming by c-Met
-
批准号:8303038
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2012
-
负责人:John J Laterra
-
依托单位:
Brain Cancer Stem Cell Reprogramming by c-Met
-
批准号:8662816
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2012
-
负责人:John J Laterra
-
依托单位:
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9
-
批准号:8333318
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2011
-
负责人:John J Laterra
-
依托单位:
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9
-
批准号:8517228
-
项目类别:
-
资助金额:$31.27万
-
财政年份:2011
-
负责人:John J Laterra
-
依托单位:
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9
-
批准号:8716822
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2011
-
负责人:John J Laterra
-
依托单位:
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9
-
批准号:8221135
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2011
-
负责人:John J Laterra
-
依托单位:
Neutralizing Anti-HGF mAbs and CNS Malignancy
-
批准号:7470020
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2007
-
负责人:John J Laterra
-
依托单位:
Neutralizing Anti-HGF mAbs and CNS Malignancy
-
批准号:7644455
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2007
-
负责人:John J Laterra
-
依托单位:
Neutralizing Anti-HGF mAbs and CNS Malignancy
-
批准号:7880030
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2007
-
负责人:John J Laterra
-
依托单位:
Neutralizing Anti-HGF mAbs and CNS Malignancy
-
批准号:7299276
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2007
-
负责人:John J Laterra
-
依托单位:
Mechanisms of Chemo/Radioresistance in Human Gliomas
-
批准号:7694331
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2003
-
负责人:John J Laterra
-
依托单位:
海外基金